These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28024127)

  • 1. Combined therapy in vulvar lichen sclerosus: does topical tretinoin improve the efficacy of mometasone furoate?
    Borghi A; Minghetti S; Toni G; Virgili A; Corazza M
    J Dermatolog Treat; 2017 Sep; 28(6):559-563. PubMed ID: 28024127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mometasone furoate in the treatment of vulvar lichen sclerosus: could its formulation influence efficacy, tolerability and adherence to treatment?
    Corazza M; Virgili A; Toni G; Borghi A
    J Dermatolog Treat; 2018 May; 29(3):305-309. PubMed ID: 28753097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous vs. tapering application of the potent topical corticosteroid mometasone furoate in the treatment of vulvar lichen sclerosus: results of a randomized trial.
    Borghi A; Corazza M; Minghetti S; Toni G; Virgili A
    Br J Dermatol; 2015 Dec; 173(6):1381-6. PubMed ID: 26280156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining topical tretinoin with mometasone furoate in the treatment of vulvar lichen sclerosus: Results of dermoscopic assessment.
    Corazza M; Maietti E; Toni G; Virgili A; Borghi A
    Dermatol Ther; 2018 Nov; 31(6):e12735. PubMed ID: 30334327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vulvar lichen sclerosus: a comparison of the short-term topical application of clobetasol dipropionate 0.05% versus mometasone furoate 0.1%.
    Murina F; Rehman S; Di Francesco S; Mantegazza V; Felice R; Bianco V
    J Low Genit Tract Dis; 2015 Apr; 19(2):149-51. PubMed ID: 25023331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clobetasol propionate vs. mometasone furoate in 1-year proactive maintenance therapy of vulvar lichen sclerosus: results from a comparative trial.
    Corazza M; Borghi A; Minghetti S; Toni G; Virgili A
    J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):956-61. PubMed ID: 25904498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study.
    Virgili A; Minghetti S; Borghi A; Corazza M
    Br J Dermatol; 2013 Jun; 168(6):1316-24. PubMed ID: 23398459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First randomized trial on clobetasol propionate and mometasone furoate in the treatment of vulvar lichen sclerosus: results of efficacy and tolerability.
    Virgili A; Borghi A; Toni G; Minghetti S; Corazza M
    Br J Dermatol; 2014 Aug; 171(2):388-96. PubMed ID: 24641522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growing evidence for topical mometasone fuoroate in the treatment of Vulvar Lichen Sclerosus.
    Virgili A; Corazza M; Minghetti S; Borghi A
    Maturitas; 2015 Jan; 80(1):113-5. PubMed ID: 25449823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical tretinoin in the treatment of vulvar lichen sclerosus: an advisable option?
    Borghi A; Corazza M; Minghetti S; Virgili A
    Eur J Dermatol; 2015; 25(5):404-9. PubMed ID: 26243060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and dermoscopic changes of vulvar lichen sclerosus after topical corticosteroid treatment.
    Borghi A; Corazza M; Minghetti S; Toni G; Virgili A
    J Dermatol; 2016 Sep; 43(9):1078-82. PubMed ID: 27075682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mometasone fuoroate 0.1% ointment in the treatment of vulvar lichen sclerosus: a study of efficacy and safety on a large cohort of patients.
    Virgili A; Borghi A; Minghetti S; Corazza M
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):943-8. PubMed ID: 23879234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does longer duration of corticosteroid treatment improve clearance in vulvar lichen sclerosus? Results from a single centre, comparative, open label study.
    Corazza M; Toni G; Valpiani G; Morotti C; Borghi A
    Dermatol Ther; 2021 Jul; 34(4):e14955. PubMed ID: 33835646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Therapeutic Approaches and Targets for Treatment of Vulvar Lichen Sclerosus.
    Borghi A; Corazza M
    Curr Pharm Biotechnol; 2021; 22(1):99-114. PubMed ID: 32416670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical mometasone furoate for vulvar lichen sclerosus.
    Cattaneo A; De Magnis A; Botti E; Sonni L; Carli P; Taddei GL
    J Reprod Med; 2003 Jun; 48(6):444-8. PubMed ID: 12856516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Tolerability of Mometasone Furoate in Lichen Sclerosus: Further Confirming Evidence.
    Virgili A; Minghetti S; Corazza M; Borghi A
    J Low Genit Tract Dis; 2015 Jul; 19(3):e58. PubMed ID: 26111043
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and pathological analysis of 345 cases of vulvar lichen sclerosus and a preliminary study on the frequency of maintenance treatment].
    Sun XY; Xiao YP; Sun YX; Zhang Q; Cong Q
    Zhonghua Fu Chan Ke Za Zhi; 2024 Jan; 59(1):56-63. PubMed ID: 38228516
    [No Abstract]   [Full Text] [Related]  

  • 18. Does Clearance of Vulvar Lichen Sclerosus after a Corticosteroid Treatment Correspond to a Decrease in Disease-Related Burden? Results from a Cohort Study Using Pictorial Representation of Illness and Self-Measure and the Dermatology Life Quality Index.
    Borghi A; Flacco ME; Zedde P; Toni G; Schettini N; Corazza M
    Dermatology; 2023; 239(1):81-90. PubMed ID: 36382657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term maintenance therapy for vulvar lichen sclerosus: the results of a randomized study comparing topical vitamin E with an emollient.
    Virgili A; Minghetti S; Borghi A; Corazza M
    Eur J Dermatol; 2013 Apr; 23(2):189-94. PubMed ID: 23607963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An arm-based network meta-analysis on treatments for vulvar lichen sclerosus and a call for development of core outcome sets.
    Pergialiotis V; Bellos I; Biliou EC; Varnava P; Mitsopoulou D; Doumouchtsis SK;
    Am J Obstet Gynecol; 2020 Jun; 222(6):542-550.e6. PubMed ID: 31697910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.